| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.00B | 5.83B | 5.63B | 5.86B | 5.74B | 4.54B |
| Gross Profit | 1.67B | 5.00B | 4.83B | 5.02B | 1.46B | 3.82B |
| EBITDA | 1.65B | 1.75B | 1.94B | 2.19B | 2.34B | 1.62B |
| Net Income | 93.33M | 331.80M | 596.94M | 890.75M | 1.12B | 610.86M |
Balance Sheet | ||||||
| Total Assets | 21.62B | 20.48B | 19.06B | 18.10B | 17.30B | 14.65B |
| Cash, Cash Equivalents and Short-Term Investments | 1.03B | 1.70B | 2.06B | 2.75B | 2.74B | 1.20B |
| Total Debt | 8.06B | 7.24B | 6.33B | 6.17B | 7.19B | 5.83B |
| Total Liabilities | 13.87B | 12.98B | 11.89B | 11.60B | 11.35B | 9.80B |
| Stockholders Equity | 7.74B | 7.50B | 7.17B | 6.50B | 5.95B | 4.85B |
Cash Flow | ||||||
| Free Cash Flow | 1.00B | -2.00B | -1.54B | -994.29M | -190.30M | 93.92M |
| Operating Cash Flow | 1.59B | 1.45B | 1.45B | 1.73B | 1.95B | 1.54B |
| Investing Cash Flow | -2.47B | -2.89B | -2.05B | -2.42B | -1.87B | -1.13B |
| Financing Cash Flow | 880.71M | 895.11M | 66.53M | 59.80M | 1.43B | 287.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $2.81B | 12.96 | 13.21% | 1.79% | 4.77% | -35.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $8.63B | 16.03 | 16.36% | 1.75% | 1.68% | 9.91% | |
59 Neutral | $9.35B | ― | 1.22% | ― | 4.32% | -55.65% | |
51 Neutral | $10.58B | -5.08 | 32.05% | ― | -1.22% | -639.34% | |
51 Neutral | $1.97B | -2.13 | 193.77% | ― | -7.36% | 62.27% | |
47 Neutral | $3.44B | 4,644.29 | 0.06% | 1.79% | 19.40% | -120.47% |